Tenaya Therapeutics to Announce Initial Data From Mypeak-1 Phase 1B/2 Clinical Trial of Tn-201 Gene Therapy for Mybpc3-Associated Hypertrophic Cardiomyopathy on Tuesday, December 17, 2024
Tenaya Therapeutics將於2024年12月17日星期二公佈Mypeak-1 1B/2期臨床試驗中Tn-201基因療法針對Mybpc3相關性肥厚型心肌病的初步數據。
